Aclarion to Showcase Key 2026 Catalysts and Strong Balance Sheet at ROTH Conference
ByAinvest
Tuesday, Mar 17, 2026 6:02 am ET1min read
ACON--
Aclarion, a healthcare technology company, will participate in the 38th Annual ROTH Conference to discuss its progress advancing Nociscan, a proprietary MR spectroscopy platform designed to help physicians identify painful discs in patients with chronic low back pain. CEO Brent Ness will engage in one-on-one meetings with institutional investors and analysts to discuss the company's progress and upcoming catalysts. The company has a strong balance sheet and plans to expand adoption of Nociscan in the UK and US.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet